is the fda stopping the sale of tirzepatide Mounjaro will remain off shortage list after review Tirzepatide Lawsuit Against the FDA:

Over one-third of patients with type 2 diabetes were classified as non-responders compared to less than a quarter of patients without diabetes (without type 2 diabetes: 77.3% responders and 22.7% non-responders

Comparing thigh injection experience across GLP-1 medications If you have experience with other GLP-1 receptor agonists, the thigh injection technique is largely the same

Combining Mounjaro injection for weight loss with insulin or similar medicines may increase the risk of low blood sugar and requires close monitoring

Caution in patients with GI disease or history of thyroid cancer

Getting this wrong means getting the wrong dose